Immunoassay for Colistin Monitoring in Critically Ill Patients Receiving Colistin Methanesulfonate Therapy

<b>Background/Objectives</b>: Colistin (COL), administered as a prodrug colistimethate sodium (CMS), is commonly used to treat infections caused by multidrug-resistant Gram-negative bacteria in critically ill patients. Given high CMS instability, very complex and variable pharmacokinetic...

詳細記述

書誌詳細

出版年:	Pharmaceuticals
主要な著者:	Yury A. Surovoy, Inna A. Galvidis, Akmal I. Alimov, Zhanhui Wang, Artem O. Melekhin, Maksim A. Burkin
フォーマット:	論文
言語:	英語
出版事項:	MDPI AG 2026-06-01
主題:	colistin polymyxins therapeutic drug monitoring ELISA pharmacokinetics
オンライン･アクセス:	https://www.mdpi.com/1424-8247/19/6/880